Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.125 USD | -1.73% | -9.62% | +148.00% |
05-08 | Lexaria Bioscience Corp. Begins Dosing of Its Second Glp-1 Human Pilot Study | CI |
04-16 | Lexaria Obtains Ethics Review Board Approval to Start New GLP-1 Study | MT |
- Stock Market
- Equities
- LEXX Stock
- News Lexaria Bioscience Corp.
- MarketScreener Editorial Features